FDA — authorised 15 April 2003
- Application: NDA021598
- Marketing authorisation holder: HARROW EYE
- Local brand name: VIGAMOX
- Indication: SOLUTION/DROPS — OPHTHALMIC
- Status: approved
🇺🇸 Moxifloxacin 0.5% ophthalmic solution in United States
FDA authorised Moxifloxacin 0.5% ophthalmic solution on 15 April 2003
Marketing authorisation
Other Ophthalmology / Infectious Disease approved in United States
Frequently asked questions
Is Moxifloxacin 0.5% ophthalmic solution approved in United States?
Yes. FDA authorised it on 15 April 2003.
Who is the marketing authorisation holder for Moxifloxacin 0.5% ophthalmic solution in United States?
HARROW EYE holds the US marketing authorisation.